Reynolds Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-1,800
| Closed | -$343K | – | 167 |
|
|
2015
Q4 | $343K | Sell |
1,800
-100
| -5% | -$19.1K | 0.37% | 83 |
|
|
2015
Q3 | $297K | Buy |
1,900
+300
| +19% | +$46.9K | 0.37% | 97 |
|
|
2015
Q2 | $289K | Sell |
1,600
-3,500
| -69% | -$632K | 0.28% | 137 |
|
|
2015
Q1 | $884K | Buy |
5,100
+400
| +9% | +$69.3K | 0.77% | 22 |
|
|
2014
Q4 | $870K | Buy |
4,700
+800
| +21% | +$148K | 0.72% | 27 |
|
|
2014
Q3 | $647K | Buy |
3,900
+1,200
| +44% | +$199K | 0.63% | 41 |
|
|
2014
Q2 | $422K | Buy |
2,700
+400
| +17% | +$62.5K | 0.29% | 114 |
|
|
2014
Q1 | $350K | Buy |
2,300
+500
| +28% | +$76.1K | 0.23% | 180 |
|
|
2013
Q4 | $239K | Sell |
1,800
-2,000
| -53% | -$266K | 0.13% | 316 |
|
|
2013
Q3 | $441K | Buy |
3,800
+200
| +6% | +$23.2K | 0.29% | 102 |
|
|
2013
Q2 | $333K | Buy |
+3,600
| New | +$333K | 0.24% | 155 |
|